Journal profile

Journal of investigational allergology & clinical immunology

Publisher: Esmon Publicidad
ISSN1018-9068 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.04
Citation rate 2.07 357 total citations
h5-index 24 h5 depth signal
Cited share 59.8% 110 of 184
Total citations 357 Citation footprint
Metric signal 1.91 External metric anchor
Self-citation 0.0% 0 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

Spain 708
Italy 82
Portugal 49
Germany 42
France 40

Citing Fields of Research

Allergies 852
Immunology 167
Auto-Inflammatory Disorders 83
Hematology 79
Dermatology 46

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 1,138 Articles tracked across the journal lifetime
Indexed publication set 184 110 cited publications
Last 12 months 117 10.6 publications/month
Open access share 1.7% 2 OA publications in the last year
Leading citing country Spain 708 citing publications
Leading citing field Allergies 852 citing publications
Latest tracked publication 19 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v1n1,Feb. 1991-
PubMed
v1n1,Feb. 1991-
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Allergies

Issuing & Sponsoring Bodies

Contributor
International Association of Asthmology
Contributor
Sociedad Latinoamericana de Alergia e Inmunología
Contributor
Sociedad Española de Alergología e Inmunología Clínica

Broad Categories

Allergy and Immunology Allergies

MeSH Descriptors

Hypersensitivity Immunity

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01
Juan Carlos Miralles-López, Ismael García-Moguel, Alicia Habernau-Mena et al.
Asthma is a chronic inflammatory disease of the airways affecting more than 300 million people worldwide. It is estimated that between 3% and 10% have severe asthma. Depemokimab is the first ultra-long-acting anti–IL-5 monoclonal antibod...
06
Alberto Caballero-Vázquez, Bélgica Márquez-Lobo, Javier L. López-Hidalgo et al.
Background: Histopathological analysis of bronchial tissue in patients with severe asthma makes it possible to characterize inflammatory and remodeling phenomena that are not identifiable using noninvasive biomarkers. Although bronchial ...
08
Rosialzira N Vera-Berrios, Alejandro Gonzalo-Fernández, Barbara K Ballmer-Weber et al.
Background: Oral food challenge, particularly double-blind placebo-controlled food challenge (DBPCFC), is the gold standard for diagnosis of food allergy, although safety concerns limit its widespread use. Objectives: To evaluate the sev...
10
Marina Pérez-Gordo, Roberto Álvarez-Lafuente, Joan Bartra et al.
The gut microbiota constitutes a highly complex ecosystem that plays a pivotal role in maintaining human health and modulating the immune response. Dysbiosis, an imbalance in the composition of gut microbiota, has been linked to the deve...

Bibliographical & Catalog Notes

Called also: JIACI.

Title from cover.

Also issued online.

Articles in English; summaries in English and Spanish.

Official organ of: International Association of Asthmology (INTERASMA), 1991- ; Sociedad Latinoamericana de Alergia e Inmunología, 1991-<2004>; Spanish Society of Allergology and Clinical Immunology, 2006- .